Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes
Vasundhara Mathur, Katherine Wasden, Thomas Shin, Pourya Medhati, Abdelrahman Nimeri, Ali Tavakkoli, Eric G. Sheu
Abstract
This case-control study examines the use of glucagon-like peptide-1 receptor agonist before metabolic and bariatric surgery and its postoperative outcome.
Topics & Concepts
MedicineSemaglutideWeight lossSurgeryGlucagon-like peptide 1 receptorAgonistGlucagon-like peptide-1General surgeryObesityInternal medicineType 2 diabetesDiabetes mellitusLiraglutideReceptorEndocrinologyBariatric Surgery and OutcomesDiabetes Treatment and ManagementPharmacology and Obesity Treatment